Yes. For the Patient-Centered Economic Outcomes Supplement, only awarded multi-site studies in good standing that were funded under PCORI PFAs issued in Cycle 1 2019 or later are eligible. For the Diversity/Equity Supplement, only awarded studies that are in good standing that were funded under PCORI PFAs issued in Cycle 1 2021 or later are eligible. Eligibility for the Diversity/Equity Supplemental funding opportunity is limited to those that are more recently awarded so that efforts to increase diversity and/or advance health equity can be started earlier on in the study.
Do the eligibility criteria for each supplement differ?
Have more questions? Submit a request